Literature DB >> 21681675

Lobectomy by video-assisted thoracoscopic surgery (VATS) for early stage of non-small cell lung cancer.

Min Zhu1, Xiang-Ning Fu, Xiaoping Chen.   

Abstract

Video-assisted thoracoscopic surgery (VATS) provides a new approach for treating early-stage lung cancer. Lobectomy by VATS has many advantages over conventional thoracotomy, such as shorter recovery time, less postoperative pain, and faster resumption of a normal lifestyle. However, there is still much debate on the role of VATS in lobectomy for the treatment of lung cancer. Concerns regarding safety, the extent of mediastinal lymph node dissection, and long-term survival have made some surgeons apprehensive of its validity for lung cancer. In this paper, we review the development of thoracoscopy, the present status of VATS for early stage of non-small cell lung cancer (NSCLC), and comparison between VATS and open thoracotomy in the management of NSCLC.

Entities:  

Mesh：

Year:  2011        PMID： 21681675     DOI： 10.1007/s11684-011-0121-2

Source DB:  PubMed          Journal:  Front Med        ISSN： 2095-0217            Impact factor:   4.592


  67 in total

1.  Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database.

Authors:  Subroto Paul; Nasser K Altorki; Shubin Sheng; Paul C Lee; David H Harpole; Mark W Onaitis; Brendon M Stiles; Jeffrey L Port; Thomas A D'Amico
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02       Impact factor: 5.209

2.  Video-assisted thoracic surgical non-rib spreading simultaneously stapled lobectomy: a more patient-friendly oncologic resection.

Authors:  R J Lewis; R J Caccavale; J P Bocage; M D Widmann
Journal:  Chest       Date:  1999-10       Impact factor: 9.410

3.  Acute phase responses following minimal access and conventional thoracic surgery.

Authors:  S R Craig; H A Leaver; P L Yap; G C Pugh; W S Walker
Journal:  Eur J Cardiothorac Surg       Date:  2001-09       Impact factor: 4.191

4.  VATS lobectomy reduces cytokine responses compared with conventional surgery.

Authors:  A P Yim; S Wan; T W Lee; A A Arifi
Journal:  Ann Thorac Surg       Date:  2000-07       Impact factor: 4.330

5.  Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer.

Authors:  Rebecca P Petersen; DuyKhanh Pham; William R Burfeind; Steven I Hanish; Eric M Toloza; David H Harpole; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

6.  Locoregional control of thoracoscopic lobectomy with selective lymphadenectomy for lung cancer.

Authors:  Junji Ichinose; Tadasu Kohno; Sakashi Fujimori; Mingyon Mun
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

7.  Video-assisted thoracic surgery (VATS) lobectomy: the Edinburgh experience.

Authors:  W S Walker
Journal:  Semin Thorac Cardiovasc Surg       Date:  1998-10

8.  Videoendoscopic pulmonary lobectomy for cancer.

Authors:  G Roviaro; C Rebuffat; F Varoli; C Vergani; C Mariani; M Maciocco
Journal:  Surg Laparosc Endosc       Date:  1992-09

9.  Difference in the impairment of vital capacity and 6-minute walking after a lobectomy performed by thoracoscopic surgery, an anterior limited thoracotomy, an anteroaxillary thoracotomy, and a posterolateral thoracotomy.

Authors:  Hiroaki Nomori; Takashi Ohtsuka; Hirotoshi Horio; Tsuguo Naruke; Keiichi Suemasu
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

10.  Safety and efficacy of video-assisted versus conventional lung resection for lung cancer.

Authors:  Farhood Farjah; Douglas E Wood; Michael S Mulligan; Bahirathan Krishnadasan; Patrick J Heagerty; Rebecca Gaston Symons; David R Flum
Journal:  J Thorac Cardiovasc Surg       Date:  2009-03-09       Impact factor: 5.209
View more
  1 in total

1.  Video-assisted thoracoscopic surgery versus muscle-sparing thoracotomy for non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Zihuai Wang; Long Pang; Jiexi Tang; Jiahan Cheng; Nan Chen; Jian Zhou; Lunxu Liu
Journal:  BMC Surg       Date:  2019-10-15       Impact factor: 2.102
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.